Understanding Mechanisms of Action of Beta-Blockers in Heart Failure With Reduced and Preserved Ejection Fraction

Affiliations

¹ Norwich Medical School, University of East Anglia, and Norfolk and Norwich University Hospitals, Norwich, United Kingdom. Electronic address: m.flather@uea.ac.uk.
² Norwich Medical School, University of East Anglia, and Norfolk and Norwich University Hospitals, Norwich, United Kingdom.

Editorial

Marcus D Flather et al. JACC Heart Fail. 2016 Feb.

. 2016 Feb;4(2):150-151.

doi: 10.1016/j.jchf.2015.12.009.

¹ Norwich Medical School, University of East Anglia, and Norfolk and Norwich University Hospitals, Norwich, United Kingdom. Electronic address: m.flather@uea.ac.uk.
² Norwich Medical School, University of East Anglia, and Norfolk and Norwich University Hospitals, Norwich, United Kingdom.

No abstract available

Keywords: HFpEF; HFrEF; beta-blockers; heart failure.

Comment on

Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
Edelmann F, Musial-Bright L, Gelbrich G, Trippel T, Radenovic S, Wachter R, Inkrot S, Loncar G, Tahirovic E, Celic V, Veskovic J, Zdravkovic M, Lainscak M, Apostolović S, Neskovic AN, Pieske B, Düngen HD; CIBIS-ELD Investigators and Project Multicenter Trials in the Competence Network Heart Failure. Edelmann F, et al. JACC Heart Fail. 2016 Feb;4(2):140-149. doi: 10.1016/j.jchf.2015.10.008. Epub 2015 Dec 9. JACC Heart Fail. 2016. PMID: 26682793 Clinical Trial.